A Prospective Study on Prevalence of Hyperprolactinemia & Hypothyroidism in Benign Breast Diseases
Background: Benign breast disorders are usually come across in Indian clinical practice. Due to Cultural inhibitions many Indian women don’t turn up for breast related problem. Therefore, they are unaware of the breast changes that usually occur, and these changes may be normal or abnormal. Methods: Fifty cases were included in this study on the bases of clinical symptoms. This study conducted in the department of surgery, Madhubani Medical College, Bihar. The duration was study was six months. Data were collected on the bases of clinical symptoms & serum was collected for the estimation of TSH & prolactin.
Results: ‘Prevalence of serum prolactin & TSH estimation done for all the patients and revealed that 22% cases had hyperprolactinemia & 24% had thyroids.
Conclusion: The results of our study conclude that strengthen the association of thyroid dysfunction with benign breast disease.
2. Dawson C, Armstrong MW, Michaels J et al (1993) Breast disease and the general surgeon. II. Effect of audit on the referral of patients with breast problems. Ann R Coll Surg Engl75:83-86
3. Goehring C, Morabia A (1997) Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 19:310–327
4. Peters F, Schuth W, Scheurich B et al (1984) Serum prolactin levels in patients with fibrocystic breast disease. Obstet Gynecol 64:381–385
5. Adamopoulos DA, Vassilaros S, Kapolla N et al (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125–128
6. Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients
7. Pradeep Tanwar et al. 2016 Magnitude of Hypothyroidism in Benign Breast Disorders and Effect of Thyroxin Replacement on Clinical Outcome of Benign Breast Disorders with Hypothyroidism as Comorbidity International Journal of Health Sciences & Research (www.ijhsr.org) 61 Vol.6; Issue: 6 2249-9571
8. Venturi S (2001) Is there a role for iodine in breast diseases? Breast 10:379– 382
9. Saraiva PP, Figueiredo NB, Padovani CR et al (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761–765
10. Cristofanilli M, Yamamura Y, Kau SW et al (2005) Thyroid hormone and breast carcinoma: primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103:1122–1128
11. Goehring C, Morabia A (1997) Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 19:310–327
12. Surks MI, Ortiz E, Daniels GH et al (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228–238
13. Vanderpump MP, Tunbridge WH, French JM (1995) The incidence of thyroid
disorders in the community: a twenty-year follow- up of the Whickham survey.
Clin Endocrinol (Oxf) 43:55–68
14. Arrigo T, Wasniewska M, Crisafulli G et al (2008) Subclinical hypothyroidism: the
state of the art. J Endocrinol Invest 31:79
Copyright (c) 2019 Mohd Tarique and IABCR
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.